WUT_task_1___2_.docx C155 PATHOPHARMACOLOGICAL FOUNDATIONS FOR ADVANCED NURSING PRACTICE Obesity WUT Task 1– C155: Western Governors University Introduction Obesity rates are continuously rising and have been
...
WUT_task_1___2_.docx C155 PATHOPHARMACOLOGICAL FOUNDATIONS FOR ADVANCED NURSING PRACTICE Obesity WUT Task 1– C155: Western Governors University Introduction Obesity rates are continuously rising and have been for the past 30 years, creating what may be considered ag “global public health crisis. ‘‘Globally it is estimated that 500 million adults have obesity worldwide, with rates increasing among children and adolescents. Data from the National Health and Nutrition Examination Surveys shows, that “2 out of 3 adults are overweight or obese in the United States. (Brett, Garber, Garvey et.al., 2016). Obesity increases the risk for morbidity from other comorbidities such as hypertension, dyslipidemia, type 2 diabetes, coronary heart disease, stroke, gallbladder disease, osteoarthritis, respiratory problems, and cancer. The economic and psychosocial consequences of obesity have considerable implications for the health and wellness of united states citizens. The impact of obesity on morbidity, mortality, and health care cost are tremendous. Obesity is major contributor to chronic diseases in the United and, as such, presents the US health systems with a major public health challenge. Clinical guidelines on overweight and obesity have been established to address and identify risks associated with overweight and obesity and the health effects of weight loss. The obesity guidelines present proven treatment strategies for weight loss that include “diet modification, physical activit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . .
[Show More]